In our news wrap Tuesday, Pfizer agreed to cut prescription drug prices as part of a deal that spares the company from ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pfizer is a generally well-run company and the current headwinds aren't really unusual. The pharma giant cut its dividend, while peers Merck and Bristol-Myers Squibb did not. It's not the only ...

President Donald Trump and Pfizer's CEO today announced "TrumpRX" and lower drug prices. But what does Pfizer sell? Here's their popular drugs.

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with President Donald Trump's administration. Trump made ...